Aceglatone
Aceglatone (Glucaron) is an antineoplastic drug available in Japan.[2]
Clinical data | |
---|---|
Trade names | Glucaron |
Other names | D-Glucaric acid di-γ-lactone 2,5-diacetate 2,5-Di-O-acetyl-D-glucaro-1,4:6,3-dilactone 2,5-Di-O-acetyl-D-glucosaccharo-1,4:6,3-dilactone |
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H10O8 |
Molar mass | 258.182 g·mol−1 |
3D model (JSmol) | |
Melting point | 185 to 186 °C (365 to 367 °F) [1] |
SMILES
| |
InChI
| |
(what is this?) (verify) |
It is an inhibitor of the enzyme β-glucuronidase.[3]
References
- Merck Index, 11th Edition, 20
- Glucaron, drugs.com
- Iida R, Nagata S, Kakimoto M, Akaike H, Watanabe H, Shioya A (1965). "2,5-Di-O-acetyl-D-glucosaccharo-(1→4)(6→3)-dilactone, a new potent β-glucuronidase inhibitor". Japanese Journal of Pharmacology. 15 (1): 88–90. doi:10.1254/jjp.15.88. PMID 14348597.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.